CRO Commitment Pressure-Test for Biotech Clinical Operations

A pre-send gate for clinical operations directors at small biotechs (20-200 person, running Phase II/III trials) who depend on 1-3 CROs to deliver patient recruitment, site activation, and database-lock milestones. When the CRO sends its monthly commitment ('FPI July 18; 30 sites active by end Q3'), the director enters the commitment plus the assumptions backing it. AE's adversarial multi-model debate stress-tests those assumptions against the director's accumulating miss-pattern ledger from prior milestones — surfacing which assumption classes (site readiness, IRB timing, screening conversion) historically collapse for THIS CRO on THIS trial type. Weeks later, the director marks the resolved CTMS outcome; AE's constraint language promotes patterns that predicted accurately and demotes those that didn't. AE is uniquely suited because adversarial multi-model debate plus a code-enforced grading loop is exactly what CTMS and Veeva lack — they store milestones, they don't interrogate them. No patient data ever leaves the director's environment; only commitment text and resolved milestone dates.

AE turns CRO commitments into graded, trial-specific predictions — interrogating the assumptions CTMS only stores — for a single high-stakes buyer who can justify five-figure ACV without SaaS overhead.

Still in evaluation (phase: ranked). No verdict yet.